Skip to content

Syncona Portfolio Ltd

Follow

13F filer, CIK 1725042, St Peter Port, Guernsey, United Kingdom

Syncona Portfolio Ltd reported $34,322,024 across 2 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-05.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001193125-26-038529

Period
2025-12-31
Reported value
$34.3M
Holdings
2
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001193125-26-038529, largest first. % of portfolio is the value over $34,322,024, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 18,554,624 shares; 2024Q4: 16,640,720 shares; 2025Q1: 16,640,720 shares; 2025Q2: 16,640,720 shares; 2025Q3: 16,640,720 shares; 2025Q4: 16,640,720 shares 16,640,720$33.1M96.48%0Timeline
IPSCCENTURY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,213,056 shares; 2024Q4: 1,213,056 shares; 2025Q1: 1,213,056 shares; 2025Q2: 1,213,056 shares; 2025Q3: 1,213,056 shares; 2025Q4: 1,213,056 shares 1,213,056$1.21M3.52%0Timeline

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-26-038529 base2026-02-05acceptance time not in the bulk data set